Quest Diagnostics Incorporated · NYSE:DGX

Delaney Mark E reported 1 trade in Quest Diagnostics Incorporated shares (Form 4)

Traded Oct 21, 2026 · Filed Oct 23, 2026

On Oct 21, 2026, Delaney Mark E (SVP & Chief Commercial Officer) reported 1 trade in Quest Diagnostics Incorporated shares at US$235.94 for US$5,899, leaving 10,360 shares. Filed Oct 23, 2026 (Form 4).

Shares
25 shares
Price
US$235.94
Value
US$5,899
Holding after
10,360 shares
Trading plan
No
Role
SVP & Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 21, 2026Common StockOther25US$235.9410,360Direct

Source

Download original · View original at SEC

Related